Meaningful Use stage 2 e-prescribing threshold and adverse drug events in the Medicare Part D population with diabetes.
Powers C, Gabriel MH, Encinosa W, Mostashari F, Bynum J. J Am Med Inform Assoc. 2015 May 6; [Epub ahead of print].
This analysis of Medicare data found that outpatient practices using electronic prescribing had fewer adverse drug events among their panel of patients with diabetes compared to practices not consistently using electronic prescribing. Although promising, this study does not address the many differences between practices that use electronic prescribing versus those that do not and the patients that select these disparate health care systems.
A long-term follow-up evaluation of electronic health record prescribing safety.
Abramson EL, Malhotra S, Osorio SN, et al. J Am Med Inform Assoc. 2013;20:e52-e58.
Health IT Patient Safety Action and Surveillance Plan.
Washington, DC: Office of the National Coordinator for Health Information Technology; July 2, 2013.
ECRI announces top 10 healthcare technology hazards.
Clark C. HealthLeaders Media. November 5, 2013.
COMMENTARYView all related resources...
Advancing the science of measurement of diagnostic errors in healthcare: the Safer Dx framework.
Singh H, Sittig DF. BMJ Qual Saf. 2015;24:103-110.